BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2009
View Archived Issues
Novel flavivirus-based vaccine protects against Dengue virus type 2 in mice
Read More
Pharmacokinetics, toxicity of IQP-0410 investigated in dogs
Read More
Alfadolone confers antinociception in rat models of inflammation
Read More
Avexa provides update on merger with Progen
Read More
Bavituximab achieves primary endpoint in phase II breast cancer study
Read More
Living Cell Technologies reports interim Diabecell Implants results
Read More
Prezista available for pediatric patients as part of HIV combination therapy
Read More
Genta submits tesetaxel trial proposal for SPA in advanced gastric cancer
Read More
Endo signs research collaboration agreements with Harvard University and Aurigene
Read More
Oxygen to file in Switzerland for phase II clinical trial of Oxycyte in TBI
Read More
TorreyPines reports positive results from phase I clinical trial of NGX-426 in healthy subjects
Read More
VasoGenix selects lead CGRP agonist analogue to develop for heart failure
Read More
Chewable antiretroviral therapy combination viable in HIV-infected children
Read More